As of 2026-02-13, the EV/EBITDA ratio of Asensus Surgical Inc (ASXC) is -1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASXC's latest enterprise value is 87.93 mil USD. ASXC's TTM EBITDA according to its financial statements is -75.08 mil USD. Dividing these 2 quantities gives us the above ASXC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 22.2x | 20.1x |
| Forward P/E multiples | 21.5x - 25.6x | 24.0x |
| Fair Price | (5.88) - (6.09) | (6.04) |
| Upside | -1790.0% - -1850.1% | -1836.6% |
| Date | EV/EBITDA |